MOBERG PHARMA

What this means for you

Not registered yet, but its 12 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98849569

Mark type

Design + words

Filed

12 Nov 2024

Attorney of record

Donna J. Bunton

Goods and services

• Class 003 — Cosmetics and cleaning preparations: Cosmetics, hair lotions, dentifrices, foot care preparations in the nature of foot masks for skincare, cosmetical products, namely, liquids, creams, lotions, gels, foams, sprays, pastes, pumice pastes and powders for use on the skin, nails or scalp; make-up, facial cleansers, skin creams, soaps for personal use, hair shampoo, personal deodorants for hygienic purposes, toothpastes, non-medicated foot-cleaning preparations, deodorants for feet, foot deodorant sprays; moisturizing preparations for the skin, in particular foot sprays; moisturizing solutions for the skin in the nature of emollient creams and hair emollients for moisturizing hair; moisturizing creams in the nature of emollient creams for nail care; cotton sticks for cleansing for cosmetic purposes, cotton wool for cosmetic purposes, shaving creams, after-shave preparations, nail-care preparation, pre-moistened wipes for cosmetic purposes; all of the foregoing nonmedicated
• Class 005 — Pharmaceuticals: Pharmaceutical preparations, for the purpose of treating skin, scalp and nail conditions, fungal and bacterial infections, joint pain, muscle pain, cough, congestion, sinus, cold, flu and allergy symptoms, pharmaceutical preparations for use in the fields of dermatology, gerontology/aging, urology, gynecology, oncology, pediatrics, infectious diseases, pain relief, arthritis and osteoarthritis; sanitary preparations for medical purposes; cotton sticks for cleansing for medical purposes; medical and surgical plasters; disinfectant preparations, namely, pharmaceutical preparations with antimicrobial, emollient and/or ceratolytic properties in the form of liquids, gels, creams, lotions, sprays, foams or plaster patches for treating warts and other lesions of the epidermis and to loosen or dissolve dry, flakey, callused, and scaly skin or scalp; dermatological preparations for medical use; medical preparations for the treatment of dandruff; medicated dandruff shampoo, medicated dandruff conditioner; medical preparations for the treatment of psoriasis, a topical eczema; medical preparations for the treatment and prevention of acne, athletes foot and other dermatological foot conditions, vaginal fungal infection and other fungal infections; pre-moistened wipes containing antibiotics for medical purposes, absorbent cotton wool for medical purposes, breast pads, tampons, plasters and dressings pre-treated with medicines for the treatment and prevention of fungal infections; medical preparations for the treatment of joint pain and muscle pain; medicated bath preparations; diagnostic preparations for medical purposes; mouthwashes for medical purposes; chewing gum for medical purposes; emollient creams for medical purposes; surgical compresses pre-treated with preparations for treating fungal infections; pharmaceutical preparations for treatment of actinic keratosis, genital warts, basal cell carcinoma and skin cancer; acne treatment preparations; disinfectant soap; medicated foot sprays for treating conditions of the nails, skin or scalp; emollients for medical purposes, namely, emollient creams for treating conditions of the nails, skin or scalp; medicated and non-medicated acne care preparations; Inhalers filled with oxygen for medical use; inhalers filled with hydrogen for medical use
• Class 010 — Medical apparatus: Medical instruments and medical devices for the application and/or dosing of medicines, namely, dosage dispensers for administering medicine to patients, drug delivery patches sold without medication, inhalers sold empty for medical use, intravenous bags sold empty for intravenous therapy; medical devices for the application and/or dosing of medicines for the treatment or prevention of skin diseases and infections of the mucous membranes, namely, dosage dispensers for administering medicine to patients, drug delivery patches sold without medication, inhalers for medical use sold empty, intravenous bags sold empty for intravenous therapy; syringes for medical purposes and for injections, implants consisting of artificial materials, contraceptive apparatus in the nature of vaginal rings, vaginal syringes, medical devices for retarding the effect of medical substances and for delivering medicines to the body for the treatment or prevention of skin diseases and infections of the mucous membranes, namely, transdermal drug delivery patches sold without medication, electronic-kinetic transdermal drug delivery control unit for the treatment of disease
• Class 035 — Advertising and business services: Advertising services; business management; business administration; providing office functions; advertising services in the fields of pharmaceutical products, cosmetic products and medical devices; commercial assistance in business management; demonstration of goods for promotional purposes; distribution of samples for publicity purposes; import-export agency services; provision of commercial information; medical cost management; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; providing physician referrals

Owner

• Moberg Pharma AB (publ), BROMMA, SE

Prosecution history

• 14 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 14 Jan 2026 — NON-FINAL ACTION E-MAILED
• 14 Jan 2026 — NON-FINAL ACTION WRITTEN
• 05 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 05 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 05 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 14 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 14 Sept 2025 — NON-FINAL ACTION E-MAILED
• 14 Sept 2025 — NON-FINAL ACTION WRITTEN
• 12 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 12 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 12 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 May 2025 — NON-FINAL ACTION E-MAILED
• 12 May 2025 — NON-FINAL ACTION WRITTEN